NOLTREX® | CLINICAL EVIDENCE
Proven Results.
Extensive Clinical Trials.
Noltrex® is a treatment of choice supported by significant clinical practice since 2003. It is recognized as well-tolerated, safe, and effective for patients with osteoarthritis in various large joints, including the knee, hip and ankle.
14
CLINICAL STUDIES
Across the Russian Federation and CIS countries
104
WEEKS
Long-term efficacy proven for up to 104 weeks
2003
CLINICAL PRACTICE
Supported by significant clinical practice since 2003
SELECTED CLINICAL RESEARCH
Registered Clinical Studies
Noltrex® has been evaluated in registered clinical studies examining its use in knee osteoarthritis and long-term follow-up.
A multicentre, double-blind, randomized placebo-controlled study evaluating the efficacy and safety of Noltrex® in knee osteoarthritis.
An open-label multicentre extension study evaluating the long-term efficacy and safety of Noltrex® in knee osteoarthritis.
A one-year follow-up study evaluating the long-term efficacy and safety of Noltrex® in patients with knee osteoarthritis.
PATIENT OUTCOMES
500+ Patients. Consistent Benefits.
In a study involving more than 500 patients, significant benefits were reported regardless of disease stage.
500+
PATIENTS
SIGNIFICANT BENEFITS
Reported regardless of disease stage
NOLTREX® | ANTIMICROBIAL PROPERTIES
Bacteriostatic Activity.
Tests demonstrated bacteriostatic activity against selected bacterial strains, including S. aureus, E. coli and P. aeruginosa.
ACTIVITY OBSERVED AGAINST
Selected Bacterial Strains
●
S. AUREUS
MSSA & MRSA
●
E. COLI
●
P. AERUGINOSA
Looking for More Clinical Information?
Detailed clinical and product information is available upon request.